EUVIMEDEUVIMED entdecken
Crossref

Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension

Stefano Masi, Claudio Borghi

European Journal of Internal Medicine · 2026-08 · 150 · 106922

DOI: 10.1016/j.ejim.2026.106922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2026-08. Verfasst von Stefano Masi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Italy. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Department of Medical and Surgical Sciences-University of Bologna, Italy. Electronic address: claudio.borghi@unibo.it.

Zitieren

APA

Masi, S., & Borghi, C. (2026). Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension. European Journal of Internal Medicine, 150, 106922. https://doi.org/10.1016/j.ejim.2026.106922

Vancouver

Masi S, Borghi C. Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension. European Journal of Internal Medicine. 2026;150:106922. doi:10.1016/j.ejim.2026.106922

BibTeX
@article{Masi2026,
  author = {Masi, Stefano and Borghi, Claudio},
  title = {Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension},
  journal = {European Journal of Internal Medicine},
  year = {2026},
  volume = {150},
  pages = {106922},
  doi = {10.1016/j.ejim.2026.106922}
}
Kostenlos starten →